Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats

Inflammopharmacology

Volumn 14, Issue 1-2, 2006, Pages 36-41

  Bykov, I L ^a   Palmen, M ^a   Rainsford, K D ^b   Lindros, K O ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Alcoholic liver steatosis; Celecoxib; Cyclo oxygenase inhibition; Cytokines; Prostaglandins

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CELL INFILTRATION; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG EFFECT; HISTOPATHOLOGY; INFLAMMATION; LIVER WEIGHT; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ALANINE TRANSAMINASE; ANIMALS; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ETHANOL; FATTY LIVER; LIVER; MALE; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; SULFONAMIDES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646240596     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-1506-8     Document Type: Article

References (35)

1. Alegria, P., Lebre, L., Chagas, C. (2002) Celecoxib-induced cholestatic hepatotoxicity in a patient with cirrhosis. Ann Intern Med. 137, 75.
2. Arai, M., Peng, X. X., Currin, R. T., Thurman, R. G., Lemasters, J. J. (1999) Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E2 derived from Kupffer cells. Transplantation 68, 440-445.
3. Breyer, R. M., Bagdassarian, C. K., Myers, S. A., Breyer, M. D. (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 41, 661-690.
4. Bykov, I. L., Vakeva, A., Jarvelainen, H. A., Meri, S., Lindros, K. O. (2004) Protective function of complement against alcohol-induced rat liver damage. Int Immunopharmacol. 4, 1445-1454.
5. Chung, J., Liu, C., Smith, D. E., Seitz, H. K., Russell, R. M., Wang, X. D. (2001) Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis 22, 1213-1219.
6. Davies, N. M., McLachlan, A. J., Day, R. O., Williams, K. M. (2000) Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet. 38, 225-242.
7. 2 is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol. 279, G100-G106.
8. Fennekohl, A., Sugimoto, Y., Segi, E., Maruyama, T., Ichikawa, A., Puschel, G. P. (2002) Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol. 36, 328-334.
9. Hardy, P., Bhattacharya, M., Abran, D., Peri, K. G., Asselin, P., Varma, D. R., Chemtob, S., Bhatthacharya, M. (1998) Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition. Invest Ophthalmol Vis Sci. 39, 1888-1898.
10. Hines, I. N., Wheeler, M. D. (2004) Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol. 287, G310-G314.
11. Hu, K. Q. (2003) Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot Essent Fatty Acids. 69, 329-337.
12. Hu, Y, Ingelman-Sundberg, M., Lindros, K. O. (1995) Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation. Biochem Pharmacol. 50, 155-161.
13. Kasai, K., Sato, S., Suzuki, K. (2001) A novel prostaglandin E receptor subtype agonist, ONO-4819, attenuates acute experimental liver injury in rats. Hepatol Res. 21, 252-260.
14. Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., Remick, D. (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 263, 5380-5384.
15. Lindros, K. O., Järvelä, H. A. (1998) A new oral low-carbohydrate alcohol liquid diet producing liver lesions: a preliminary account. Alcohol Alcohol. 33, 347-353.
16. Lipsky, P. E. (1999) Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop. 28, 8-12.
17. Nakatani, Y., Kitazawa, T., Fujimoto, M., Tamura, N., Uemura, M., Yamao, J., Fukui, H. (2004) Effect of prostaglandin E receptor subtype EP4 selective agonist on the secretion of tumor necrosis factor-alpha by macrophages in acute ethanol-loaded rats. Alcohol Clin Exp Res. 28, 123S-128S.
18. Nanji, A. A., Khettry, U., Sadrzadeh, S. M., Yamanaka, T. (1993) Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am J Pathol 142, 367-373.
19. Nanji, A. A., Miao, L., Thomas, P., Rahemtulla, A., Khwaja, S., Zhao, S., Peters, D., Tahan, S. R., Dannenberg, A. J. (1997) Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology. 112, 943-951.
20. Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Brautigam, L., Grosch, S., Geisslinger, G. (2001) Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J. 15, 1622-1624.
21. Oinonen, T. and Lindros, K. O. (1995) Hormonal regulation of the zonated expression of ccytochrome P-450 3A in rat liver. Biochem J. 309, 55-61.
22. Okita, M., Sasagawa, T., Ohta, Y., Kaneyuki, T., Suzuki, K. (2001) Effect of arachidonic acid-rich oil on lipids and arachidonate metabolites in ethanol- treated rats. Prostaglandins Leukot Essent Fatty Acids 64, 273-279.
23. Quiroga, J., Prieto, J. (1993) Liver cytoprotection by prostaglandins. Pharmacol Ther. 58, 67-91.
24. Reilly, T. P., Brady, J. N., Marchick, M. R., Bourdi, M., George, J. W., Radonovich, M. F., Pise-Masison, C. A., Pohl, L. R. (2001) A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol. 14, 1620-1628.
25. Rainsford, K. D. (2004) Pharmacology and Toxicology of COX-2 Inhibitors. In: "COX-2 Inhibitors", Milestones in Drug Therapy Series. Eds. M. Pairet and J-A Van Ryn; Birkhäuser, Basel, 67-131.
26. Simon, L. S., Weaver, A. L., Graham, D. Y., Kivitz, A. J., Lipsky, P. E., Hubbard, R. C., Isakson, P. C., Verburg, K. M., Yu, S. S., Zhao, W. W., Geis, G. S. (1999) Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA. 282, 1921-1928.
27. Smith, W. L., DeWitt, D. L., Garavito, R. M. (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145-182.
28. Spitzer, J. A., Zheng, M., Kolls, J. K., Vande Stouwe, C., Spitzer, J. J. (2002) Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivo. Front Biosci. 7, a99-a108.
29. Stewart, S., Jones, D., Day, C. P. (2001) Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med. 7, 408-413.
30. Szabo, G., Mandrekar, P. (2002) Ethanol-mediated regulation of transcription factors in immunocompetent cells. Front Biosci. 7, a 8089.
31. Tanaka, M., Ishibashi, H., Hirata, Y., Miki, K., Kudo, J., Niho, Y. (1996) Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2. J Clin Lab Immunol. 48, 17-31.
32. Teoh, N. C., Farrell, G. C. (2003) Hepatotoxicity associated with non-steroidal anti-inflammatory drugs. Clin Liver Dis. 7, 401-413.
33. Warner, T. D., Mitchell, J. A. (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J. 18, 790-804.
34. Yamamoto, H., Kondo, M., Nakamori, S., Nagano, H., Wakasa, K., Sugita, Y., Chang-De, J., Kobayashi, S., Damdinsuren, B., Dono, K., Umeshita, K., Sekimoto, M., Sakon, M., Matsuura, N., Monden, M. (2003) JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology. 125, 556-571.
35. Yi, H., Wang, X., Miao, J. Y., Du, J. P., Pan, Y. L., Liu, N., Zhang, X. M., Fan, D. M. (2003) Protective effect of selective cyclooxygenase-2 inhibitor on alcohol-induced liver injury in rats. Zhonghua Gan Zang Bing Za Zhi. 11, 663-666.